| 0 |
TISSUE INFILTRATION |
2 |
0.0068 |
| 1 |
INTESTINAL SEPSIS |
1 |
0.0038 |
| 2 |
SIMILAR REACTION ON PREVIOUS EXPOSURE TO DRUG |
1 |
0.0033 |
| 3 |
INFUSION SITE IRRITATION |
4 |
0.0031 |
| 4 |
FEAR OF DEATH |
7 |
0.0031 |
| 5 |
PERFORMANCE STATUS DECREASED |
14 |
0.0030 |
| 6 |
ADMINISTRATION SITE REACTION |
1 |
0.0026 |
| 7 |
PHLEBITIS |
8 |
0.0016 |
| 8 |
BICYTOPENIA |
3 |
0.0015 |
| 9 |
PROCEDURAL ANXIETY |
1 |
0.0015 |
| 10 |
INFECTIOUS PLEURAL EFFUSION |
2 |
0.0013 |
| 11 |
PSYCHIATRIC SYMPTOM |
8 |
0.0011 |
| 12 |
GRANULOCYTE COUNT DECREASED |
2 |
0.0011 |
| 13 |
WRONG SCHEDULE |
1 |
0.0010 |
| 14 |
MYELOSUPPRESSION |
37 |
0.0010 |
| 15 |
DEVICE RELATED THROMBOSIS |
1 |
0.0010 |
| 16 |
INFUSION SITE PAIN |
11 |
0.0009 |
| 17 |
INFUSION SITE REACTION |
2 |
0.0007 |
| 18 |
INFUSION SITE ERYTHEMA |
5 |
0.0006 |
| 19 |
HYPOPITUITARISM |
1 |
0.0006 |
| 20 |
EXTRAVASATION |
2 |
0.0005 |
| 21 |
FEBRILE BONE MARROW APLASIA |
2 |
0.0005 |
| 22 |
CARDIAC FAILURE CHRONIC |
2 |
0.0005 |
| 23 |
COLORECTAL CANCER METASTATIC |
1 |
0.0004 |
| 24 |
GASTROINTESTINAL OBSTRUCTION |
1 |
0.0004 |
| 25 |
PHYSICAL DECONDITIONING |
1 |
0.0004 |
| 26 |
RED BLOOD CELL COUNT DECREASED |
11 |
0.0004 |
| 27 |
IMMUNE-MEDIATED MYOSITIS |
1 |
0.0004 |
| 28 |
CEREBRAL THROMBOSIS |
1 |
0.0004 |
| 29 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 30 |
NEAR DEATH EXPERIENCE |
1 |
0.0003 |
| 31 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
1 |
0.0003 |
| 32 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 33 |
BLOOD PHOSPHORUS DECREASED |
1 |
0.0003 |
| 34 |
PROTEIN TOTAL DECREASED |
1 |
0.0003 |
| 35 |
HYPERPYREXIA |
1 |
0.0002 |
| 36 |
INTERCEPTED MEDICATION ERROR |
1 |
0.0002 |
| 37 |
PULSE ABSENT |
1 |
0.0002 |
| 38 |
INCORRECT DOSAGE ADMINISTERED |
1 |
0.0002 |
| 39 |
VEIN DISORDER |
1 |
0.0002 |
| 40 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 41 |
NEUTROPHIL COUNT DECREASED |
8 |
0.0002 |
| 42 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 43 |
WHITE BLOOD CELL COUNT DECREASED |
19 |
0.0002 |
| 44 |
SKIN WARM |
1 |
0.0002 |
| 45 |
PERIPHERAL SENSORY NEUROPATHY |
1 |
0.0002 |
| 46 |
PLATELET COUNT DECREASED |
18 |
0.0002 |
| 47 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
8 |
0.0002 |
| 48 |
INJECTION SITE EXTRAVASATION |
2 |
0.0002 |
| 49 |
INFUSION SITE EXTRAVASATION |
1 |
0.0002 |
| 50 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
2 |
0.0002 |
| 51 |
NERVOUSNESS |
8 |
0.0002 |
| 52 |
DEPRESSED MOOD |
8 |
0.0002 |
| 53 |
HYPOPHOSPHATAEMIA |
1 |
0.0001 |
| 54 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 55 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 56 |
MYOSITIS |
1 |
0.0001 |
| 57 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 58 |
UROSEPSIS |
1 |
0.0001 |
| 59 |
CHEST DISCOMFORT |
11 |
0.0001 |
| 60 |
HAEMORRHAGE |
11 |
0.0001 |
| 61 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 62 |
BRAIN INJURY |
1 |
0.0001 |
| 63 |
SEPSIS |
11 |
0.0001 |
| 64 |
ALANINE AMINOTRANSFERASE INCREASED |
6 |
0.0001 |
| 65 |
INJECTION SITE DISCOMFORT |
1 |
0.0001 |
| 66 |
SUDDEN DEATH |
1 |
0.0001 |
| 67 |
PULMONARY THROMBOSIS |
1 |
0.0001 |
| 68 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 69 |
INFECTION |
12 |
0.0001 |
| 70 |
CYTOPENIA |
1 |
0.0001 |
| 71 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 72 |
ABNORMAL WEIGHT GAIN |
1 |
0.0001 |
| 73 |
ILEUS |
1 |
0.0001 |
| 74 |
INJECTION SITE DISCOLOURATION |
1 |
0.0001 |
| 75 |
INJECTION SITE IRRITATION |
1 |
0.0001 |
| 76 |
ADVERSE REACTION |
1 |
0.0001 |
| 77 |
TACHYPNOEA |
1 |
0.0001 |
| 78 |
PNEUMONITIS |
2 |
0.0001 |
| 79 |
ANAEMIA |
14 |
0.0001 |
| 80 |
INJECTION SITE REACTION |
5 |
0.0001 |
| 81 |
BURNING SENSATION |
5 |
0.0001 |
| 82 |
HYPOKALAEMIA |
3 |
0.0001 |
| 83 |
FEBRILE NEUTROPENIA |
4 |
0.0001 |
| 84 |
FACE OEDEMA |
1 |
0.0001 |
| 85 |
NEUROTOXICITY |
1 |
0.0001 |
| 86 |
DRUG ERUPTION |
1 |
0.0001 |
| 87 |
PROTEINURIA |
1 |
0.0001 |
| 88 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 89 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 90 |
NEUTROPENIA |
7 |
0.0001 |
| 91 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 92 |
PNEUMONIA |
15 |
0.0000 |
| 93 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 94 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
1 |
0.0000 |
| 95 |
TRANSAMINASES INCREASED |
1 |
0.0000 |
| 96 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 97 |
CHROMATURIA |
1 |
0.0000 |
| 98 |
PRESYNCOPE |
1 |
0.0000 |
| 99 |
CEREBRAL INFARCTION |
1 |
0.0000 |
| 100 |
ALOPECIA |
8 |
0.0000 |
| 101 |
LEUKOPENIA |
2 |
0.0000 |
| 102 |
SOMNOLENCE |
8 |
0.0000 |
| 103 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 104 |
DIPLOPIA |
1 |
0.0000 |
| 105 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 106 |
ASPARTATE AMINOTRANSFERASE INCREASED |
2 |
0.0000 |
| 107 |
CARDIAC FAILURE |
3 |
0.0000 |
| 108 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 109 |
HAEMOPTYSIS |
1 |
0.0000 |
| 110 |
COUGH |
10 |
0.0000 |
| 111 |
HYPONATRAEMIA |
2 |
0.0000 |
| 112 |
INTENTIONAL DOSE OMISSION |
1 |
0.0000 |
| 113 |
LIVER FUNCTION TEST ABNORMAL |
1 |
0.0000 |
| 114 |
RENAL INJURY |
1 |
0.0000 |
| 115 |
DYSPNOEA |
19 |
0.0000 |
| 116 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 117 |
HYPOTHYROIDISM |
1 |
0.0000 |
| 118 |
OFF LABEL USE |
27 |
0.0000 |
| 119 |
DEEP VEIN THROMBOSIS |
2 |
0.0000 |
| 120 |
INFUSION RELATED REACTION |
2 |
0.0000 |
| 121 |
SYNCOPE |
3 |
0.0000 |
| 122 |
FLUSHING |
3 |
0.0000 |
| 123 |
WEIGHT DECREASED |
8 |
0.0000 |
| 124 |
ANXIETY |
8 |
0.0000 |
| 125 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 126 |
RESPIRATORY FAILURE |
2 |
0.0000 |
| 127 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 128 |
EPISTAXIS |
2 |
0.0000 |
| 129 |
ASTHENIA |
10 |
0.0000 |
| 130 |
HOT FLUSH |
2 |
0.0000 |
| 131 |
PYREXIA |
8 |
0.0000 |
| 132 |
MENTAL DISORDER |
1 |
0.0000 |
| 133 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 134 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 135 |
COMA |
1 |
0.0000 |
| 136 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 137 |
DEATH |
16 |
0.0000 |
| 138 |
MALAISE |
8 |
0.0000 |
| 139 |
MEDICATION ERROR |
1 |
0.0000 |
| 140 |
PANCYTOPENIA |
1 |
0.0000 |
| 141 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 142 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 143 |
PALPITATIONS |
2 |
0.0000 |
| 144 |
DISEASE PROGRESSION |
2 |
0.0000 |
| 145 |
FATIGUE |
13 |
0.0000 |
| 146 |
STOMATITIS |
1 |
0.0000 |
| 147 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 148 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 149 |
NAUSEA |
13 |
0.0000 |
| 150 |
DISCOMFORT |
1 |
0.0000 |
| 151 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 152 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 153 |
SWELLING FACE |
1 |
0.0000 |
| 154 |
DEHYDRATION |
2 |
0.0000 |
| 155 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 156 |
PAIN |
9 |
0.0000 |
| 157 |
ERYTHEMA |
3 |
0.0000 |
| 158 |
HYPERTENSION |
3 |
0.0000 |
| 159 |
SKIN BURNING SENSATION |
1 |
0.0000 |
| 160 |
UNDERDOSE |
1 |
0.0000 |
| 161 |
AGITATION |
1 |
0.0000 |
| 162 |
HYPOAESTHESIA |
2 |
0.0000 |
| 163 |
UNEVALUABLE EVENT |
1 |
0.0000 |
| 164 |
INJECTION SITE PAIN |
4 |
0.0000 |
| 165 |
DECREASED APPETITE |
3 |
0.0000 |
| 166 |
VOMITING |
6 |
0.0000 |
| 167 |
DIZZINESS |
6 |
0.0000 |
| 168 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 169 |
RASH |
5 |
0.0000 |
| 170 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 171 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 172 |
COVID-19 |
2 |
0.0000 |
| 173 |
MUSCLE SPASMS |
2 |
0.0000 |
| 174 |
ADVERSE EVENT |
1 |
0.0000 |
| 175 |
CHEST PAIN |
2 |
0.0000 |
| 176 |
HYPERSENSITIVITY |
2 |
0.0000 |
| 177 |
CARDIAC DISORDER |
1 |
0.0000 |
| 178 |
SWELLING |
1 |
0.0000 |
| 179 |
HEART RATE INCREASED |
1 |
0.0000 |
| 180 |
HAEMOGLOBIN DECREASED |
1 |
0.0000 |
| 181 |
CONSTIPATION |
2 |
0.0000 |
| 182 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 183 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 184 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 185 |
PRODUCT USE IN UNAPPROVED INDICATION |
2 |
0.0000 |
| 186 |
VISUAL IMPAIRMENT |
1 |
0.0000 |
| 187 |
HEADACHE |
5 |
0.0000 |
| 188 |
RENAL FAILURE |
1 |
0.0000 |
| 189 |
INSOMNIA |
2 |
0.0000 |
| 190 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 191 |
PRODUCT DOSE OMISSION ISSUE |
2 |
0.0000 |
| 192 |
PARAESTHESIA |
1 |
0.0000 |
| 193 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 194 |
TREMOR |
1 |
0.0000 |
| 195 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 196 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 197 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 198 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 199 |
DIARRHOEA |
3 |
0.0000 |
| 200 |
PAIN IN EXTREMITY |
1 |
0.0000 |
| 201 |
DRUG INEFFECTIVE |
4 |
0.0000 |
| 202 |
FALL |
1 |
0.0000 |
| 203 |
PRURITUS |
1 |
0.0000 |
| 204 |
ARTHRALGIA |
1 |
0.0000 |